Spyre Therapeutics Inc (SYRE)

CapEx to Revenue

0.00%

Quarterly · Period ending:

SYRE logo

SYRE CapEx to Revenue

Latest reported0.00%
SYRE Quarterly CapEx/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

SYRE capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.5747%
0%
2.7166%
0%
6.6476%
0.219%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.4718%
5.4967%
12.888%
8.8025%
3.1102%
27.5967%
9.7033%
0%
6.4822%
0.2328%
2.5237%
12.4884%
0.7003%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.